Alnylam PharmaceuticalsALNY 
$274.950.18%24h
0.18%24h
Global rank529
Market cap$34.34B
Change 7d5.57%
YTD Performance44.80%
SP500 benchmarkOutperform
P/E-78.11
P/S18.78
Revenue$1.83B
Earnings-$440.24M
Dividend yield-
Main Sector
Healthcare
Alnylam Pharmaceuticals (ALNY) Net Assets
ALNY Net Assets in 2023: $-220.64M
As of 7 Dec 2024, Alnylam Pharmaceuticals net assets is $-220.64M, an increase of 39.45% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Alnylam Pharmaceuticals overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Alnylam Pharmaceuticals Net Assets History from 2018 to 2024
-
Value:-
ALNY Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $-220.64M | 39.45% |
| 2022 | $-158.22M | -126.90% |
| 2021 | $588.20M | -42.12% |
| 2020 | $1.02B | -29.36% |
| 2019 | $1.44B | -150.07% |
| 2018 | $-2.87B | - |
View the Top Net Assets Companies
